Capricor Therapeutics shares are trading higher Friday after the company reported Q2 earnings on Thursday after market close. The report appears to be supporting the stock, but the article provides no specific financial metrics (revenue/EPS) or guidance changes.
Capricor Therapeutics shares are trading higher Friday after the company reported Q2 earnings on Thursday after market close. The report appears to be supporting the stock, but the article provides no specific financial metrics (revenue/EPS) or guidance changes.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
